Inspira Technologies Oxy B.H.N. Ltd. Warrant 2021-30.06.26 on INSPIRA TECH IINNW 深 沪
已收盘 02-06 16:00:00 美东时间
0.2743
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.2743
- 总市值 0
- 52周最高 0.99
- 市盈率 静 --
- 换手率 NaN.00%
- 52周最低 0.125
- 委 比 -33.33%
- 总股本 --
- 历史最高 2.90
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.00
- 每 手 1
- 风险率 0.10%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Inspira Technologies Successfully Achieved All Key Strategic Objectives In Its High-Level Talks With A Government Health Authority For Nationwide Adoption Of ART100 System, Paving Way For Global Expansion
Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN, IINNW))) ("Inspira," "Inspira Technologies," or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced it has
2025-07-10 21:27
Inspira™ Introduces Advanced Features for INSPIRA™ ART100, Further Amplifying User and System Support
RA'ANANA, Israel, Jan. 27, 2025 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira," or the "Company"), a leader in innovative medical technology, has annou...
2025-01-27 21:30
Inspira™ Technologies Prepares its First Life-Support Systems for Deployment at a Leading U.S. Hospital
RA'ANANA, Israel, Jan. 22, 2025 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW), ("Inspira Technologies," "Inspira" or the "Company"), a groundbreaking re...
2025-01-22 21:30
Inspira™ Receives Israeli Regulatory Approval for the INSPIRA™ ART100 System
Approval follows the FDA clearance announced on May 28, 2024 RA'ANANA, Israel, July 11, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Compa...
2024-07-11 20:30
Inspira™ Announces Business Plan Targets
Company to aggressively promote INSPIRA™ ART100 in the U.S. and additional markets following FDA clearance, as well as accelerate plans for ground-breaking INSPIRA™ ART (Gen2) RA'ANANA, Isra...
2024-06-20 21:25
INSPIRA™ ART100 Receives FDA 510(k) Clearance
RA'ANANA, Israel, May 28, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company", "Inspira", or "Inspira Technologies"), a breakthrough medi...
2024-05-28 21:25
Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures
RA'ANANA, Israel, April 16, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company,...
2024-04-16 20:42
Inspira Nears First FDA 510(K) Approval, 3 US Patents Approved, $546M in Summary Distribution Agreements
Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) (NASDAQ:IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology company, has announced that the Company is
2024-02-27 20:15
Inspira Announces $3.88 Million Registered Direct Offering
RA'ANANA, Israel, Dec. 26, 2023 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira"), a pioneer in life support technology with a...
2023-12-27 03:16
Inspira Technologies to Participate in J.P. Morgan Healthcare Conference
RA'ANANA, Israel, Dec. 18, 2023 /PRNewswire/ -- Inspira Technologies OXY BHN Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a pioneer in life support technology with a vi...
2023-12-18 21:30
